(S)-Methyl pyrrolidine-3-carboxylate hydrochloride, 95.0%, 10g

2-(m-Tolyl)thiazole-4-carbaldehyde, 95.0%, 250mg

(1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropyl)methanol, 95.0%, 1g

4-(4-Fluorobenzylamino)-1-methylpiperidine, 98%, 100g

Ethylboronic acid, 97.0%, 10g

Diethylenetriaminepentaacetic acid, min. 99%, for synthesis, 500 g, plastic packaging.

4-aminobenzoic acid, min. 98.5%, for synthesis, 250 g, plastic packaging.

2-(methoxymethoxy)aniline, 95.0%, 100mg

2,2,3,3,4,4,5,5,6,6-Decafluoro-6-[(1,2,2-trifluorovinyl)oxy]hexanenitrile>98.0%(GC)25g

1-(2-Aminothiazol-4-yl)ethanone, 95.0%, 5g

Screw vials free-standing, 2 ml, 1000 Piece(s)

2-Methoxy-3-nitrobenzoic acid, 95.0%, 25g

Acetonitrile ROTIDRY®, min. 99.9% (max.10 ppm H2O), 2.5 l, glass packaging